Your browser doesn't support javascript.
loading
Syndrome of inappropriate secretion of anti-diuretic hormone due to hypothalamic hamartoma: use of tolvaptan.
Moon, Rebecca Jane; Soliman, Maisara; Hoogenboom, Lieke; Gilbert, Rodney D; Bird-Lieberman, Georgina; Singh, Jaspal; Bockenhauer, Detlef; Kumaran, Anitha.
Afiliación
  • Moon RJ; Department of Paediatric Endocrinology, Southampton Children's Hospital, University Hospital Southampton NHS Foundation Trust, Southampton, UK.
  • Soliman M; MRC Lifecourse Epidemiology Centre, University of Southampton, Southampton, UK.
  • Hoogenboom L; Department of Paediatrics, Frimley Park Hospital, Guildford, UK.
  • Gilbert RD; Department of Paediatric Nephrology, Bristol Royal Hospital for Children, Bristol, UK.
  • Bird-Lieberman G; Department of Paediatric Nephrology, Southampton Children's Hospital, University Hospital Southampton NHS Foundation Trust, Southampton, UK.
  • Singh J; Department of Paediatric Neurology, Southampton Children's Hospital, University Hospital Southampton NHS Foundation Trust, Southampton, UK.
  • Bockenhauer D; Department of Paediatric Neurology, Southampton Children's Hospital, University Hospital Southampton NHS Foundation Trust, Southampton, UK.
  • Kumaran A; Department of Paediatric Nephrology, Great Ormond Street Hospital, London, UK.
J Pediatr Endocrinol Metab ; 36(9): 895-899, 2023 Sep 26.
Article en En | MEDLINE | ID: mdl-37327191
ABSTRACT

OBJECTIVES:

Hypothalamic hamartoma (HH) typically presents with gonadotrophin-dependent precocious puberty and/or seizures. Other endocrine disturbances are rare. We describe an infant with syndrome of inappropriate secretion of anti-diuretic hormone (SIADH) and a HH. CASE PRESENTATION A 6-week-old infant presented with seizures and life-threatening hyponatremia. A HH was identified on magnetic resonance imaging. Clinical examination and biochemistry were consistent with SIADH, and serum copeptin was high during hyponatremia, further supporting this diagnosis. Tolvaptan was effective in normalizing plasma sodium and enabling liberalization of fluids to ensure sufficient nutritional intake and weight gain and manage hunger.

CONCLUSIONS:

Hyponatremia due to SIADH is novel at presentation of a HH, and can be challenging to diagnose and manage. Successful management of hyponatremia in this case was achieved using tolvaptan.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Hiponatremia / Síndrome de Secreción Inadecuada de ADH Tipo de estudio: Diagnostic_studies / Etiology_studies / Prognostic_studies Límite: Humans Idioma: En Revista: J Pediatr Endocrinol Metab Asunto de la revista: ENDOCRINOLOGIA / PEDIATRIA Año: 2023 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Hiponatremia / Síndrome de Secreción Inadecuada de ADH Tipo de estudio: Diagnostic_studies / Etiology_studies / Prognostic_studies Límite: Humans Idioma: En Revista: J Pediatr Endocrinol Metab Asunto de la revista: ENDOCRINOLOGIA / PEDIATRIA Año: 2023 Tipo del documento: Article País de afiliación: Reino Unido
...